Similarly, intraperitoneal injection of IFN-λ3 does not protect mice from infection by the hepatotropic virus Thogotovirus, but intranasal administration of IFN-λ3 confers protection from influenza A virus infection in the lungs [9]. This evidence concerns the gene IFNL3 and infection.